If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giusy Gentilcore is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 32 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Regulatory T-Lymphocytes Medicine & Life Sciences
T-cells Chemical Compounds
interferon alfa-2b Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
temozolomide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2018

  • 737 Citations
  • 14 h-Index
  • 16 Article
  • 3 Review article
  • 1 Chapter
  • 1 Comment/debate
2 Citations (Scopus)

Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells

Fratangelo, F., Camerlingo, R., Carriero, M. V., Pirozzi, G., Palmieri, G., Gentilcore, G., Ragone, C., Minopoli, M., Ascierto, P. A. & Motti, M. L., 1 Sep 2018, In : International Journal of Oncology. 53, 3, p. 1149-1159 11 p.

Research output: Contribution to journalArticle

Cell Survival
5 Citations (Scopus)

Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients

Palma, M., Hansson, L., Mulder, T. A., Adamson, L., Näsman-Glaser, B., Eriksson, I., Heimersson, K., Ryblom, H., Mozaffari, F., Svensson, A., Gentilcore, G., Österborg, A. & Mellstedt, H., 1 Jan 2018, (Accepted/In press) In : European Journal of Haematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Dendritic Cells
Granulocyte-Macrophage Colony-Stimulating Factor
26 Citations (Scopus)

T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers

Palma, M., Gentilcore, G., Heimersson, K., Mozaffari, F., Näsman-Glaser, B., Young, E., Rosenquist, R., Hansson, L., Österborg, A. & Mellstedt, H., 28 Feb 2017, In : Haematologica. 102, 3, p. 562-572 11 p.

Research output: Contribution to journalArticle

T-Cell Prolymphocytic Leukemia
CTLA-4 Antigen
B-Cell Chronic Lymphocytic Leukemia
Regulatory T-Lymphocytes
36 Citations (Scopus)

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy

Mozzillo, N., Simeone, E., Benedetto, L., Curvietto, M., Giannarelli, D., Gentilcore, G., Camerlingo, R., Capone, M., Madonna, G., Festino, L., Caracò, C., Di Monta, G., Marone, U., Di Marzo, M., Grimaldi, A. M., Mori, S., Ciliberto, G. & Ascierto, P. A., 1 Jan 2015, In : OncoImmunology. 4, 6

Research output: Contribution to journalArticle

CTLA-4 Antigen

Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation

Pico de Coaña, Y., Wolodarski, M., Gentilcore, G., Yoshimoto, Y., Poschke, I., Hansson, J., Masucci, G. V. & Kiessling, R., 15 Jan 2015, (Accepted/In press) In : Journal of Translational Medicine. p. 1 1 p.

Research output: Contribution to journalArticle